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VALVE REPLACEMENT ASSOCIATED WITH INCREASED 
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INTRODUCTION
 Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis. 
 As TAVR procedures increase, more data is available on complications. One such complication is the 
development of conduction abnormalities post procedure. Often time conduction abnormalities require 
pacemaker placement to maintain cardiac conduction.
 The higher rate of conduction abnormalities post-TAVR represents one of the main limitations of this 
treatment approach compared with traditional valve replacement through transthoracic cardiac surgery.
 A common sequelae of pacemaker lead placement is the development of tricuspid regurgitation (TR) 
due to wire impingement of leaflet function and coaptation.
PURPOSE
 To quantify long-term sequelae of pacemaker 
implantation and its impact on the tricuspid 
valve apparatus in patients who underwent 
TAVR and subsequently developed 
conduction abnormalities requirement 
pacemaker implantation.
 To explore the effect of pacemaker 
implantation on the development of TR and 
parameters of right ventricular (RV) function. 
STUDY DESIGN
796 patients underwent TAVR from January 2014 through June 2018
89 patients (11%) underwent pacemaker implantation following TAVR procedure. 
34 patients had 2-year follow-up data post-pacemaker implantation and 
echocardiographic data obtained and compared. 
Echo data 
obtained prior to 
TAVR 
Echo data obtained 
between TAVR and PMP
Echo data obtained 
after pacemaker 
 Ejection Fraction
 Degree of TR
 Pulmonary Artery Pressure
 Tricuspid Annular Plane Systolic Excursion 
(TAPSE)
 Degree of Inferior Vena Cava Dilation
 Right Ventricular Diameter (RVD)
 Right Ventricle Systolic Pressure 
 Right Atrium (RA) Area
Age at TAVR:        79.7 yrs (± 9.0 yrs)
Sex:
Male                    19 (56%)   
Female                15 (44%)
Race:
Caucasian             30 (88%)
African-American   4 (12%)
BMI:                         29 .7 kg/m2 (± 7.0 kg/m2)
Medical Comorbidities:
Atrial Fibrillation     15 (44%)
COPD                     11 (32%)
Diabetes                 16 (47%)
Hypertension           30 (88%)
CKD                        18 (53%)
ECHOCARDIOGEAPHIC 
VARIABLES
PATIENT 
DEMOGRAPHICS
RESULTS 
 Overall, there was a trend towards increased tricuspid 
regurgitation severity at two years post-pacemaker 
implantation (from 29% to 38% following TAVR and 
PMP).
 The results additionally indicate a statistically significant 
change for the RVD, where the mean RVD increased 
from 2.9 cm to 3.5 cm (p-value = 0.039).
 While not statistically significant, it should also be noted 
that there was an increase in RA size by area evaluation.
Change In Tricuspid Severity
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CONCLUSION
 Our results demonstrate an increased incidence of worsening 
tricuspid regurgitation severity post-TAVR pacemaker implantation.  
 Further analysis indicates that in addition to developing worsening 
tricuspid regurgitation, there is evidence of early signs of right heart 
failure as manifested by increasing RV diameter in select 
populations.
 One possible hypothesis is that during TAVR  procedure, balloon 
inflation for valve anchoring leads to greater expansion of the aortic 
annulus and greater risk of injury to Koch triangle during balloon 
inflation and deployment.
 Given recent advances in transcatheter tricuspid valve therapies, 
more research is required on this complication of TAVR procedure to 
better optimize patient selection for transcatheter aortic valve 
replacement.
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